References (continued)

56. Losken A, Styblo TM, Schaefer TG, Carlson GW. The use of fluorescein dye as a predictor of mastectomy skin flap viability following autologous tissue reconstruction. Ann Plast Surg. 2008;61(1):24–29.

Continue Reading

57. Heliovaara M, Karvonen MJ, Vilhunen R, Punsar S. Smoking, carbon monoxide, and atherosclerotic diseases.Br Med J. 1978;1(6108):268–270.

58. Hawkins RI. Smoking, platelets and thrombosis. Nature. 1972;236(5348):450–452.

59. Levine PH. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation. 1973;48(3):619–623.

60. Mills E, Eyawo O, Lockhart I, Kelly S, Wu P, Ebbert JO. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med. 2011;124(2):144.e8–154.e8.

61. Manchio JV, Litchfield CR, Sati S, Bryan DJ, Weinzweig J, Vernadakis AJ. Duration of smoking cessation and its impact on skin flap survival. Plast Reconstr Surg. 2009;124(4):1105–1117.

62. Kempton SJ, Burish NM, Rao VK. Electronic cigarettes: have you asked your patients about vaping? Plast Reconstr Surg. 2014;133(6):907e.

63. Khansa I, Colakoglu S, Curtis MS, et al. Postmastectomy breast reconstruction after previous lumpectomy and radiation therapy: analysis of complications and satisfaction. Ann Plast Surg. 2011;66(5):444–451.

64. Chang EI, Vaca L, DaLio AL, Festekjian JH, Crisera CA. Assessment of advanced age as a risk factor in microvascular breast reconstruction. Ann Plast Surg. 2011;67(3):255–259.

65. Miller RB, Reece G, Kroll SS, et al. Microvascular breast reconstruction in the diabetic patient. Plast Reconstr Surg. 2007;119(1):38–45. discussion 6–8.

66. Vargas CR, Koolen PG, Anderson KE, et al. Mastectomy skin necrosis after microsurgical breast reconstruction.J Surg Res. 2015;198(2):530–534.

67. Meretoja TJ, von Smitten KA, Kuokkanen HO, Suominen SH, Jahkola TA. Complications of skin-sparing mastectomy followed by immediate breast reconstruction: a prospective randomized study comparing high-frequency radiosurgery with conventional diathermy. Ann Plast Surg. 2008;60(1):24–28.

68. Rinker B, Thornton BP. Skin-sparing mastectomy and immediate tissue expander breast reconstruction in patients with macromastia using the Passot breast reduction pattern. Ann Plast Surg. 2014;72(6):S158–S164.

69. Peled AW, Foster RD, Ligh C, Esserman LJ, Fowble B, Sbitany H. Impact of total skin-sparing mastectomy incision type on reconstructive complications following radiation therapy. Plast Reconstr Surg. 2014;134(2):169–175.

70. Robertson SA, Rusby JE, Cutress RI. Determinants of optimal mastectomy skin flap thickness. Br J Surg. 2014;101(8):899–911.

71. Larson D, Basir Z, Bruce T. Is oncologic safety compatible with a predictably viable mastectomy skin flap?Plast Reconstr Surg. 2011;127(1):27–33.

72. Beer GM, Varga Z, Budi S, Seifert B, Meyer VE. Incidence of the superficial fascia and its relevance in skin-sparing mastectomy. Cancer. 2002;94(6):1619–1625.

73. O’Connell RL, Rusby JE. Anatomy relevant to conservative mastectomy. Gland Surg. 2015;4(6):476–483.

74. Verheyden CN. Nipple-sparing total mastectomy of large breasts: the role of tissue expansion. Plast Reconstr Surg. 1998;101(6):1494–1500. discussion 501–502.

75. Newman LA, Kuerer HM, Hunt KK, et al. Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol. 1998;5(7):620–626.

76. Kroll SS, Ames F, Singletary SE, Schusterman MA. The oncologic risks of skin preservation at mastectomy when combined with immediate reconstruction of the breast. Surg Gynecol Obstet. 1991;172(1):17–20.

77. Moyer HR, Losken A. Predicting mastectomy skin flap necrosis with indocyanine green angiography: the gray area defined. Plast Reconstr Surg. 2012;129(5):1043–1048.

78. Wang F, Peled AW, Garwood E, et al. Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes. Ann Surg Oncol. 2014;21(10):3223–3230.

79. Di Candia M, Lie KH, Forouhi P, Malata CM. Experience with the Wise mammaplasty skin resection pattern in skin-sparing mastectomy and immediate breast reconstruction for large breast volumes. Int J Surg. 2011;9(1):41–45.

80. Khavanin N, Fine NA, Bethke KP, et al. Tumescent technique does not increase the risk of complication following mastectomy with immediate reconstruction. Ann Surg Oncol. 2014;21(2):384–388.

81. Carlson GW, Chu CK, Moyer HR, Duggal C, Losken A. Predictors of nipple ischemia after nipple sparing mastectomy. Breast J. 2014;20(1):69–73.

82. Gurtner GC, Jones GE, Neligan PC, et al. Intraoperative laser angiography using the SPY system: review of the literature and recommendations for use. Ann Surg Innov Res. 2013;7(1):1.

83. Barber MD, Williams L, Anderson ED, et al. Outcome of the use of acellular-dermal matrix to assist implant-based breast reconstruction in a single centre. Eur J Surg Oncol. 2015;41(1):100–105.

84. Jallali N, Ridha H, Butler PE. Postoperative monitoring of free flaps in UK plastic surgery units. Microsurgery. 2005;25(6):469–472.

85. Mothes H, Donicke T, Friedel R, Simon M, Markgraf E, Bach O. Indocyanine-green fluorescence video angiography used clinically to evaluate tissue perfusion in microsurgery. J Trauma. 2004;57(5):1018–1024.

86. Olivier WA, Hazen A, Levine JP, Soltanian H, Chung S, Gurtner GC. Reliable assessment of skin flap viability using orthogonal polarization imaging. Plast Reconstr Surg. 2003;112(2):547–555.

87. Hallock GG. Doppler sonography and color duplex imaging for planning a perforator flap. Clin Plast Surg. 2003;30(3):347–57, v–vi.

88. Heden P, Jurell G, Arnander C. Prediction of skin flap necrosis: a comparative study between laser Doppler flowmetry and fluorescein test in a rat model. Ann Plast Surg. 1986;17(6):485–488.

89. Schlosser S, Wirth R, Plock JA, Serov A, Banic A, Erni D. Application of a new laser Doppler imaging system in planning and monitoring of surgical flaps. J Biomed Opt. 2010;15(3):036023.

90. Rubben A, Eren S, Krein R, Younossi H, Bohler U, Wienert V. Infrared videoangiofluorography of the skin with indocyanine green – rat random cutaneous flap model and results in man. Microvasc Res. 1994;47(2):240–251.

91. May JW Jr, Chait LA, O’Brien BM, Hurley JV. The no-reflow phenomenon in experimental free flaps. Plast Reconstr Surg. 1978;61(2):256–267.

92. Newman MI, Samson MC, Tamburrino JF, Swartz KA. Intraoperative laser-assisted indocyanine green angiography for the evaluation of mastectomy flaps in immediate breast reconstruction. J Reconstr Microsurg. 2010;26(7):487–492.

93. Sood M, Glat P. Potential of the SPY intraoperative perfusion assessment system to reduce ischemic complications in immediate postmastectomy breast reconstruction. Ann Surg Innov Res. 2013;7(1):9.

94. Wapnir I, Dua M, Kieryn A, et al. Intraoperative imaging of nipple perfusion patterns and ischemic complications in nipple-sparing mastectomies. Ann Surg Oncol. 2014;21(1):100–106.

95. Kanuri A, Liu AS, Guo L. Whom should we SPY? A cost analysis of laser-assisted indocyanine green angiography in prevention of mastectomy skin flap necrosis during prosthesis-based breast reconstruction.Plast Reconstr Surg. 2014;133(4):448e–454e.

96. Rao R, Saint-Cyr M, Ma AM, et al. Prediction of post-operative necrosis after mastectomy: a pilot study utilizing optical diffusion imaging spectroscopy. World J Surg Oncol. 2009;7:91.

97. Mauri D, Pavlidis N, Ioannidis JP. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst. 2005;97(3):188–194.

98. Fontein DB, Charehbili A, Nortier JW, et al. Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients – a phase II trial. Eur J Cancer. 2014;50(13):2190–2200.

99. Carpenter R, Doughty JC, Cordiner C, et al. Optimum duration of neoadjuvant letrozole to permit breast conserving surgery. Breast Cancer Res Treat. 2014;144(3):569–576.

100. Gdalevitch P, Van Laeken N, Bahng S, et al. Effects of nitroglycerin ointment on mastectomy flap necrosis in immediate breast reconstruction: a randomized controlled trial. Plast Reconstr Surg. 2015;135(6):1530–1539.

101. Vilar-Compte D, Castillejos A, Hernandez-Mello N, Robles-Vidal C, Volkow P. Characteristics and treatment of surgical site complications in patients undergoing mastectomy at a cancer hospital in Mexico. Wounds. 2010;22(12):316–321.

102. Fredman R, Wise I, Friedman T, Heller L, Karni T. Skin-sparing mastectomy flap ischemia salvage using urgent hyperbaric chamber oxygen therapy: a case report. Undersea Hyperb Med. 2014;41(2):145–147.

103. Mermans JF, Tuinder S, von Meyenfeldt MF, van der Hulst RR. Hyperbaric oxygen treatment for skin flap necrosis after a mastectomy: a case study. Undersea Hyperb Med. 2012;39(3):719–723.

104. Reichl H, Hladik M, Wechselberger G. Skin banking: treatment option for native skin necrosis following skin-sparing mastectomy and previous breast irradiation. Microsurgery. 2011;31(4):314–317.

105. Heller KS, Slattery LR, Harris MN. Use of a questionably viable flap as a full thickness skin graft after mastectomy. Surg Gynecol Obstet. 1976;143(1):94–96.

106. Jensen JA, Lin JH, Kapoor N, Giuliano AE. Surgical delay of the nipple-areolar complex: a powerful technique to maximize nipple viability following nipple-sparing mastectomy. Ann Surg Oncol. 2012;19(10):3171–3176.

Source: Breast Cancer: Targets and Therapy
Originally published March 13, 2017.